atomoxetine hydrochloride has been researched along with Cognitive Dysfunction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abrol, A; Calhoun, VD; Dammer, EB; Duong, DM; Edland, SD; Fagan, AM; Galasko, D; Gámez Tansey, M; Goldstein, DS; Goldstein, FC; Hajjar, I; Hales, CM; Hanfelt, J; Higginbotham, L; Hu, WT; Lah, JJ; Levey, AI; Qiu, D; Seyfried, NT; Weinshenker, D; Wingo, TS; Zhao, L | 1 |
| Bernadzikowski, T; Boris, JR | 1 |
| Brown, JN; Ottman, AA; Warner, CB | 1 |
1 review(s) available for atomoxetine hydrochloride and Cognitive Dysfunction
| Article | Year |
|---|---|
The Role of Atomoxetine for Parkinson Disease-Related Executive Dysfunction: A Systematic Review.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Cognitive Dysfunction; Executive Function; Humans; Parkinson Disease | 2018 |
1 trial(s) available for atomoxetine hydrochloride and Cognitive Dysfunction
| Article | Year |
|---|---|
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment.
Topics: Adolescent; Adult; Alzheimer Disease; Amyloid beta-Peptides; Antigens, Neoplasm; Atomoxetine Hydrochloride; Biomarkers; Cell Adhesion Molecules; Cognitive Dysfunction; Cross-Over Studies; Double-Blind Method; Drug Repositioning; Humans; Inflammation; Middle Aged; Neuroprotection; Norepinephrine; tau Proteins | 2022 |
1 other study(ies) available for atomoxetine hydrochloride and Cognitive Dysfunction
| Article | Year |
|---|---|
Therapy for fatigue and cognitive dysfunction in postural orthostatic tachycardia syndrome.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Child; Cognitive Dysfunction; Databases, Factual; Drug Therapy, Combination; Drug Utilization; Fatigue; Female; Hospitals, Pediatric; Humans; Male; Methylphenidate; Philadelphia; Postural Orthostatic Tachycardia Syndrome; Retrospective Studies; Treatment Outcome | 2018 |